Live feed
Filing
SC 13G
SC 13G0001214659-18-001072·Bankier Alain D
Schedule 13G ownership disclosure
Intiva BioPharma Inc.
Security class unavailable · CUSIP: 46116E103
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,284,000
- Percent of class
- 5.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-18-001072
- Form type
- SC 13G
- Filer
- Bankier Alain D
- CIK
- CIK 1719591
- Filed
- Feb 12, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership